ALVOTECH

Alvotech is committed to the promise of biosimilars, which we believe can directly expand patient access to medicines globally and contribute to the overall sustainability of healthcare systems by providing lower cost alternatives to high-priced biologic medicines. This mission driven focus provides a strong basis for our corporate sustainability initiatives. We are committed to implementing a strong Environmental, Social, and Governance framework at Alvotech.

We aim to bring our portfolio and pipeline of biosimilars and biosimilar candidates to the global marketplace through our commercial partners around the world. Alvotech is in the process of transitioning from an R&D-only company into an integrated commercial stage enterprise. As we scale our production and commercialize globally, it is important that our ESG framework evolves accordingly. A strong ESG framework can help mitigate risks and identify opportunities and strengthen the relationship we have with our stakeholders.

Environmental Policy: We are committed to understanding and mitigating our impact on the natural environment. From our home-base and manufacturing hub in Reykjavik, Iceland, we can leverage the country’s abundant renewable natural resources, including clean water and renewable hydro- and geothermal energy that power a dedicated grid and supplies local industry and homes. This allows us to balance the growth of our operations and prosperity of our stakeholders, with the overarching objective of sustainability.

As a global company, we believe that our impact on the environment correlates strongly with our long-term success and value as an enterprise. We are committed to minimizing the impact we have on natural resources and climate change and recognize that this commitment starts with understanding our contribution through our energy use and CO2 emissions and continues with our dedication to mitigate the energy intensity and emissions intensity of our operations.

Environmental Sustainability Targets:

• As part of our environmental strategy ,Circular for Zero, we have set the target, that all offices and laboratories will source renewable power by 2030.
• Environmental management: We aim to have zero environmental impact across our value chain. This work is organized across the company and in our environmental management system.
• Energy consumption: Reducing energy consumption and ensuring that we transition to renewable energy are top priorities. 
• Water consumption: Every year we use billions of liters of water. All our production sites are certified according to ISO14001. his means we are committed to continuous improvements, which also includes optimizing water use.
• Waste: We distribute hundreds of millions of vials and injection pens to people who need them – and the need for our life-saving treatments is growing. Our products are made of high-quality materials, but after use, most of them end up in landfill.
• CO2 emissions: As a global company, we must think beyond our own operations when considering our environmental impact. Today, our supply chain accounts for the vast majority of our total CO2 emissions.